Dermata Therapeutics, Inc. Warrant (DRMAW) is a publicly traded PHARMACEUTICAL PREPARATIONS sector company. As of August 17, 2026, DRMAW trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. DRMAW moved +0.00% today. Year to date, DRMAW is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces DRMAW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Dermata Therapeutics, Inc. Warrant (DRMAW) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. DRMAW moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $0.00 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 146.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
DRMAW analyst coverage data. Average price target: $0.00.